A Randomized Trial of Sodium Fluoride (60 mg) plus or minus Estrogen in Postmenopausal Osteoporotic Vertebral Fractures: Increased Vertebral Fractures and Peripheral Bone Loss with Sodium Fluoride; Concurrent Estrogen Prevents Peripheral Loss, But Not Vertebral Fractures

Postmenopausal Caucasian women aged less than 80 years (n = 99) with one or more atraumatic vertebral fracture and no hip fractures, were treated by cyclical administration of enteric coated sodium fluoride (NaF) or no NaF for 27 months, with precautions to prevent excessive stimulation of bone turn...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Osteoporosis international 2002-02, Vol.13 (2), p.158-170
Hauptverfasser:	Gutteridge, D H, Stewart, GO, Prince, R L, Price, R I, Retallack, R W, Dhaliwal, S S, Stuckey, BGA, Drury, P, Jones, CE, Faulkner, D L, Kent, G N, Bhagat, C I, Nicholson, G C, Jamrozik, K
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!